Newly Proposed Therapy-Related Myelodysplastic Syndrome Prognostic Score Predicts Significant Differences in Overall Survival and Leukemia-Free Survival in Patients Treated With Azacitidine
Newly Proposed t-MDS Prognostic Score Predicts Significant Differences in Overall Survival and Leukemia-Free Survival in Patients Treated with Azacitidine / Breccia M; Fianchi L; Lunghi M; Gaidano G; Levis A; Finelli C; Santini V; Musto P; Mansueto G; Oliva EN; Leoni P; Spiriti AA; Hohaus S; Leone G; Alimena G; Voso MT. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - ELETTRONICO. - 54:(2012), pp. 1786-1787. [10.3109/10428194.2012.749406]
Newly Proposed t-MDS Prognostic Score Predicts Significant Differences in Overall Survival and Leukemia-Free Survival in Patients Treated with Azacitidine.
SANTINI, VALERIA;
2012
Abstract
Newly Proposed Therapy-Related Myelodysplastic Syndrome Prognostic Score Predicts Significant Differences in Overall Survival and Leukemia-Free Survival in Patients Treated With AzacitidineFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.